Eicosapentaenoic and docosahexaenoic acids attenuate hyperglycemia through the microbiome-gut-organs axis in db/db mice

Eicosapentaenoic and docosahexaenoic acids attenuate hyperglycemia through the microbiome-gut-organs axis in db/db mice

Abstract Background Eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) have been suggested to prevent the development of metabolic disorders. However, their individual role in treating hyperglycemia and the mechanism of action regarding gut microbiome and metabolome in the context of diabete...

Full description

Bibliographic Details
Main Authors: Pan Zhuang, Haoyu Li, Wei Jia, Qiyang Shou, Ya’er Zhu, Lei Mao, Wenqiao Wang, Fei Wu, Xiaoqian Chen, Xuzhi Wan, Yuqi Wu, Xiaohui Liu, Yin Li, Fanghuan Zhu, Lilin He, Jingnan Chen, Yu Zhang, Jingjing Jiao
Format: Article
Language:English
Published: BMC 2021-09-01
Series:Microbiome
Subjects:
Eicosapentaenoic acid
Docosahexaenoic acid
Gut microbiome
Gut metabolome
Diabetes
Online Access:https://doi.org/10.1186/s40168-021-01126-6

Internet

https://doi.org/10.1186/s40168-021-01126-6

Similar Items